Ultrasound-targeted microbubble destruction mediated herpes simplex virus-thymidine kinase gene treats hepatoma in mice
2010

Gene Therapy for Liver Cancer Using Ultrasound and Microbubbles

Sample size: 40 publication 10 minutes Evidence: moderate

Author Information

Author(s): Zhou Shiji, Li Shengwei, Liu Zuojin, Tang Yong, Wang Zhigang, Gong Jianping, Liu Changan

Primary Institution: The Second Affiliated Hospital of Chongqing Medical University

Hypothesis

Can ultrasound-targeted microbubble destruction effectively deliver the HSV-TK gene to treat hepatoma in mice?

Conclusion

Ultrasound-targeted microbubble destruction can effectively transfect the HSV-TK gene into target tissues and significantly inhibit tumors, providing a new strategy for gene therapy in liver cancer.

Supporting Evidence

  • The HSV-TK+US+MB group showed significantly higher TK protein expression compared to other groups.
  • Ultrasound-targeted microbubble destruction significantly improved the survival time of tumor-bearing mice.
  • The tumor inhibition rate was highest in the HSV-TK+US+MB group at 41.25%.

Takeaway

This study shows that using sound waves and tiny bubbles can help deliver a special gene to fight liver cancer in mice.

Methodology

Forty mice were divided into four groups and treated with different combinations of HSV-TK gene and ultrasound with microbubbles, followed by analysis of tumor growth and survival.

Potential Biases

Potential bias in the selection of treatment groups and measurement of outcomes.

Limitations

The study was conducted on mice, and results may not directly translate to humans.

Participant Demographics

40 male Kunming mice, aged 6 to 8 weeks, weighing 20 ± 2 g.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1756-9966-29-170

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication